Phoenix Bio

研究開発

研究開発

Contribution of chimeric mice with a humanized liver to the evaluation of pharmacology, toxicity, and pharmacokinetics in drug discovery and development

    Sanoh, S. Ohta, S.

    Nihon Yakurigaku Zasshi. 2018;151(5):213-220

    Chimeric mice with humanized liver: Application in drug metabolism and pharmacokinetics studies for drug discovery

      Naritomi, Y. Sanoh, S. Ohta, S.

      Drug Metab Pharmacokinet. 2017 Nov 9. pii: S1347-4367(17)30150-7. doi: 10.1016/j.dmpk.2017.11.001.

      Significance of aldehyde oxidase during drug development: Effects on drug metabolism, pharmacokinetics, toxicity, and efficacy

        Sanoh, S. Tayama, Y. Sugihara, K. Kitamura, S. Ohta, S.

        Drug Metab Pharmacokinet. 2015 Feb;30(1):52-63.

        Assessing the Therapeutic Potential of Lab-Made Hepatocytes

        Rezvani, M. Grimm, A. Willenbring, H.

        Hepatology. 2016 Mar 25. doi: 10.1002/hep.28569

        動物モデルを用いた発癌研究

        森屋恭爾、三好秀征、小池和彦

        新ウイルス性肝炎学 2015 page74-78

        肝炎ウイルスの動物モデルと治療開発

        茶山一彰、今村道雄

        新ウイルス性肝炎学 2015 page69-73

        ヒト肝細胞キメラマウスを用いたin vivoおよびin vitro HBV感染モデル

        石田雄二、横道博、加国雅和、立野知世

        新ウイルス性肝炎学 2015 page386-391

        In Vitro and in Vivo Assessments of Drug-induced Hepatotoxicity and Drug Metabolism in Humans (In Japanese)(ヒトにおける医薬品の肝毒性及び代謝物のin vtro, in vivo予測評価系の構築に関する研究)

          Sanoh, S.

          Yakugaku Zasshi. 2015;135(11):1273-9. doi: 10.1248/yakushi.15-00200.

          Assessment of chimeric mice with humanized livers in new drug development: generation of pharmacokinetics, metabolism and toxicity data for selecting the final candidate compound

            Kamimura, H. Ito, S.

            Xenobiotica. 2015 Oct 7:1-13.

            Chimeric mice transplanted with human hepatocytes as a model for prediction of human drug metabolism and pharmacokinetics

              Sanoh, S. Ohta, S.
              Biopharm Drug Dispos. 2014 Mar;35(2):71-86.

              Current status of prediction of drug disposition and toxicity in humans using chimeric mice with humanized liver

                Kitamura, S. Sugihara, K.
                Xenobiotica. 2014 Jan; 44(2): 123-34.

                A mouse with humanized liver as an animal model for predicting drug effects and for studying hepatic viral infection: where to next?

                  Yoshizato, K. Tateno, C.

                  Expert Opin Drug Metab Toxicol. 2013 Nov;9(11):1419-35.

                  Mice with liver composed of human hepatocytes as an animal model for drug testing.

                    Yoshizato K, Tateno C, Utoh R.

                    Curr Drug Discov Technol. 2012 Mar;9(1):63-76. Review.

                    Chimeric mice with humanized liver: mechanism of hepatic hyperplasia induction.

                    Tateno C.

                    生化学 2012 Aug;84(8):699-706.

                    Impact of interleukin-28B genotype on in vitro and in vivo systems of hepatitis C virus replication.

                      Chayama K, Hayes CN, Imamura M.
                      Hepatol Res. 2012 Sep;42(9):841-53.

                      ヒト肝細胞キメラマウスを用いた抗肝炎ウイルス薬効評価系

                      加国雅和、立野知世

                      ファルマシア 2012; 48(10): 956-958

                      An experimental mouse model for hepatitis C virus.

                        Kimura K, Kohara M.

                        Exp Anim. 2011;60(2):93-100. Review.

                        PBXマウス由来新鮮肝細胞を用いたインビトロ代謝試験

                        安達弥長

                        HAB Newsleter 2011; 18(1): 21-23

                        Animal model for study of human hepatitis viruses.

                          Chayama K, Hayes CN, Hiraga N, Abe H, Tsuge M, Imamura M.
                          J Gastroenterol Hepatol. 2011 Jan;26(1):13-8

                          C型肝炎感染を起こすタンパク質

                          中国新聞